Apixaban Devatis 2.5 mg
Apixaban Devatis 2.5 mg is a medicine authorised by Swissmedic under authorisation number 70399. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 April 2026 and the authorisation is limited until 14 April 2031. ATC code B01AF02 places the medicine in the group Antithrombotic agents.
| Authorisation number | 70399 |
|---|---|
| Name | Apixaban Devatis 2.5 mg |
| Full name | Apixaban Devatis 2.5 mg, Filmtabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF02 |
| First authorisation | 15 April 2026 |
| Authorisation validity | 14 April 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Apixaban Devatis 2.5 mg, Filmtabletten | B | 15 April 2026 |
| 2 | Apixaban Devatis 5 mg, Filmtabletten | B | 15 April 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 2 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 3 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 4 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 5 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 6 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 7 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Apixaban Devatis 2.5 mg authorised in Switzerland?
Yes. Apixaban Devatis 2.5 mg is authorised by Swissmedic under authorisation number 70399, data as of 01 September 2026. The authorisation is limited until 14 April 2031.
Which dispensing category does Apixaban Devatis 2.5 mg have?
Apixaban Devatis 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Apixaban Devatis 2.5 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.